Tumor lysis syndrome and metastatic melanoma.
Med Oncol
; 33(12): 134, 2016 Dec.
Article
em En
| MEDLINE
| ID: mdl-27807723
ABSTRACT
Tumor lysis syndrome (TLS) is a potential emergent complication of oncologic treatment. TLS is commonly reported in hematological malignancies with rapid cell turnover rates, but is relatively rare in solid tumors. TLS is most frequently a result of cancer treatment in combination with a large tumor burden, but has occasionally been reported to occur spontaneously, especially in cases of advanced or metastatic disease. In this article, we describe the case of a patient with newly diagnosed metastatic melanoma that developed TLS two days after initiation of corticosteroids. In addition, we present a brief literature review of melanoma-associated TLS and review the etiology, diagnosis, and management of TLS.
Palavras-chave
Buscar no Google
Base de dados:
MEDLINE
Assunto principal:
Síndrome de Lise Tumoral
/
Melanoma
Limite:
Humans
/
Male
/
Middle aged
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article